|
1.
|
Green J, Berrington de Gonzalez A,
Sweetland S, et al: Risk factors for adenocarcinoma and squamous
cell carcinoma of the cervix in women aged 20–44 years: the UK
National Case-Control Study of Cervical Cancer. Br J Cancer.
89:2078–2086. 2003.
|
|
2.
|
Pisani P, Bray F and Parkin DM: Estimates
of the world-wide prevalence of cancer for 25 sites in the adult
population. Int J Cancer. 97:72–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Termini L, Maciag PC, Soares FA, et al:
Analysis of human kallikrein 7 expression as a potential biomarker
in cervical neoplasia. Int J Cancer. 127:485–490. 2010.PubMed/NCBI
|
|
4.
|
Lockwood WW, Coe BP, Williams AC, MacAulay
C and Lam WL: Whole genome tiling path array CGH analysis of
segmental copy number alterations in cervical cancer cell lines.
Int J Cancer. 120:436–443. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Heselmeyer K, Schrock E, du Manoir S, et
al: Gain of chromosome 3q defines the transition from severe
dysplasia to invasive carcinoma of the uterine cervix. Proc Natl
Acad Sci USA. 93:479–484. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Rapp L and Chen JJ: The papillomavirus E6
proteins. Biochim Biophys Acta. 1378:F1–19. 1998.PubMed/NCBI
|
|
7.
|
Hillemanns P, Wang X, Staehle S, Michels W
and Dannecker C: Evaluation of different treatment modalities for
vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization,
photodynamic therapy, excision and vulvectomy. Gynecol Oncol.
100:271–275. 2006. View Article : Google Scholar
|
|
8.
|
Tranbaloc P: [Natural history of precursor
lesions of cervical cancer]. Gynecol Obstet Fertil. 36:650–655.
2008.(In French).
|
|
9.
|
Wilting SM, Steenbergen RD, Tijssen M, et
al: Chromosomal signatures of a subset of high-grade premalignant
cervical lesions closely resemble invasive carcinomas. Cancer Res.
69:647–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ueda Y, Enomoto T, Miyatake T, et al:
Monoclonal expansion with integration of high-risk type human
papillomaviruses is an initial step for cervical carcinogenesis:
association of clonal status and human papillomavirus infection
with clinical outcome in cervical intraepithelial neoplasia. Lab
Invest. 83:1517–1527. 2003. View Article : Google Scholar
|
|
11.
|
van Zeeburg HJ, Snijders PJ, Pals G, et
al: Generation and molecular characterization of head and neck
squamous cell lines of fanconi anemia patients. Cancer Res.
65:1271–1276. 2005.PubMed/NCBI
|
|
12.
|
van der Laan MJ, Dudoit S and Pollard KS:
Augmentation procedures for control of the generalized family-wise
error rate and tail probabilities for the proportion of false
positives. Stat Appl Genet Mol Biol. 3:Jun 15–2004.(Epub ahead of
print).
|
|
13.
|
Fitzpatrick MA, Funk MC, Gius D, et al:
Identification of chromosomal alterations important in the
development of cervical intraepithelial neoplasia and invasive
carcinoma using alignment of DNA microarray data. Gynecol Oncol.
103:458–462. 2006. View Article : Google Scholar
|
|
14.
|
Zhai Y, Kuick R, Nan B, et al: Gene
expression analysis of preinvasive and invasive cervical squamous
cell carcinomas identifies HOXC10 as a key mediator of invasion.
Cancer Res. 67:10163–10172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Alazawi W, Pett M, Strauss S, et al:
Genomic imbalances in 70 snap-frozen cervical squamous
intraepithelial lesions: associations with lesion grade, state of
the HPV16 E2 gene and clinical outcome. Br J Cancer. 91:2063–2070.
2004. View Article : Google Scholar
|
|
16.
|
Kang JU, Koo SH, Kwon KC, Park JW and Kim
JM: Identification of novel candidate target genes, including
EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of
the lung. BMC Cancer. 9:2372009.PubMed/NCBI
|
|
17.
|
Milde T, Oehme I, Korshunov A, et al:
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk
stratification and role in tumor cell growth. Clin Cancer Res.
16:3240–3252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yang Q, Jie Z, Cao H, et al: Low-level
expression of let-7a in gastric cancer and its involvement in
tumorigenesis by targeting RAB40C. Carcinogenesis. 32:713–722.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Matsuura M, Onimaru M, Yonemitsu Y, et al:
Autocrine loop between vascular endothelial growth factor (VEGF)-C
and VEGF receptor-3 positively regulates tumor-associated
lymphangiogenesis in oral squamoid cancer cells. Am J Pathol.
175:1709–1721. 2009. View Article : Google Scholar
|
|
20.
|
Habuchi H, Miyake G, Nogami K, et al:
Biosynthesis of heparan sulphate with diverse structures and
functions: two alternatively spliced forms of human heparan
sulphate 6-O-sulphotransferase-2 having different expression
patterns and properties. Biochem J. 371:131–142. 2003. View Article : Google Scholar
|
|
21.
|
Narayan G, Pulido HA, Koul S, et al:
Genetic analysis identifies putative tumor suppressor sites at
2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer
progression. Oncogene. 22:3489–3499. 2003.PubMed/NCBI
|
|
22.
|
Rao PH, Arias-Pulido H, Lu XY, et al:
Chromosomal amplifications, 3q gain and deletions of 2q33–q37 are
the frequent genetic changes in cervical carcinoma. BMC Cancer.
4:52004.
|
|
23.
|
Zimmerman ES, Chen J, Andersen JL, et al:
Human immuno-deficiency virus type 1 Vpr-mediated G2 arrest
requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX
focus formation. Mol Cell Biol. 24:9286–9294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Liang M, Ueno M, Oomizu S, et al:
Galectin-9 expression links to malignant potential of cervical
squamous cell carcinoma. J Cancer Res Clin Oncol. 134:899–907.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Tan GC, Sharifah NA, Shiran MS, Salwati S,
Hatta AZ and Paul-Ng HO: Utility of Ki-67 and p53 in distinguishing
cervical intraepithelial neoplasia 3 from squamous cell carcinoma
of the cervix. Asian Pac J Cancer Prev. 9:781–784. 2008.PubMed/NCBI
|
|
26.
|
Tonk VS, Wilson GN, Yatsenko SA, et al:
Molecular cytogenetic characterization of a familial
der(1)del(1)(p36.33)dup(1) (p36.33p36.22) with variable phenotype.
Am J Med Genet A. 139A:136–140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Chen M, Ye Y, Yang H, et al: Genome-wide
profiling of chromosomal alterations in renal cell carcinoma using
high-density single nucleotide polymorphism arrays. Int J Cancer.
125:2342–2348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Heilstedt HA, Ballif BC, Howard LA,
Kashork CD and Shaffer LG: Population data suggest that deletions
of 1p36 are a relatively common chromosome abnormality. Clin Genet.
64:310–316. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Garnis C, Coe BP, Ishkanian A, Zhang L,
Rosin MP and Lam WL: Novel regions of amplification on 8q distinct
from the MYC locus and frequently altered in oral dysplasia and
cancer. Genes Chromosomes Cancer. 39:93–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Schlaepfer DD and Mitra SK: Multiple
connections link FAK to cell motility and invasion. Curr Opin Genet
Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Luo M, Fan H, Nagy T, et al: Mammary
epithelial-specific ablation of the focal adhesion kinase
suppresses mammary tumorigenesis by affecting mammary cancer
stem/progenitor cells. Cancer Res. 69:466–474. 2009. View Article : Google Scholar
|
|
32.
|
Ohkuni T, Kojima T, Ogasawara N, et al:
Expression and localization of tricellulin in human nasal
epithelial cells in vivo and in vitro. Med Mol Morphol. 42:204–211.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Benedicto I, Molina-Jimenez F, Bartosch B,
et al: The tight junction-associated protein occludin is required
for a postbinding step in hepatitis C virus entry and infection. J
Virol. 83:8012–8020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Li W, Wang W, Si M, et al: The physical
state of HPV16 infection and its clinical significance in cancer
precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol.
134:1355–1361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Singh RK, Dasgupta S, Bhattacharya N, et
al: Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are
independently associated with the development of uterine cervical
carcinoma. J Cancer Res Clin Oncol. 131:395–406. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Gallego MI, Schoenmakers EF, van de Ven WJ
and Lazo PA: Complex genomic rearrangement within the 12q15
multiple aberration region induced by integrated human
papillomavirus 18 in a cervical carcinoma cell line. Mol Carcinog.
19:114–121. 1997. View Article : Google Scholar
|
|
37.
|
Lazo PA: The molecular genetics of
cervical carcinoma. Br J Cancer. 80:2008–2018. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Reuter S, Bartelmann M, Vogt M, et al:
APM-1, a novel human gene, identified by aberrant co-transcription
with papillomavirus oncogenes in a cervical carcinoma cell line,
encodes a BTB/POZ-zinc finger protein with growth inhibitory
activity. EMBO J. 17:215–222. 1998. View Article : Google Scholar
|
|
39.
|
Thorland EC, Myers SL, Gostout BS and
Smith DI: Common fragile sites are preferential targets for HPV16
integrations in cervical tumors. Oncogene. 22:1225–1237. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Pollack JR, Sorlie T, Perou CM, et al:
Microarray analysis reveals a major direct role of DNA copy number
alteration in the transcriptional program of human breast tumors.
Proc Natl Acad Sci USA. 99:12963–12968. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Hyman E, Kauraniemi P, Hautaniemi S, et
al: Impact of DNA amplification on gene expression patterns in
breast cancer. Cancer Res. 62:6240–6245. 2002.PubMed/NCBI
|
